Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Trading of ALTEOGEN common stock was suspended on July 16, 2026, from 15:31:00 until the close of the market following its bonus issue decision.
📊 [Key Disclosure Details & Major Figures Summary]
- Target Security: ALTEOGEN Common Stock
- Reason for Suspension: Bonus Issue
- Suspension Period:
- Suspension Date & Time: July 16, 2026, at 15:31:00
- Expiration Date: Until market close
- Regulatory Basis: Article 37 of the KOSDAQ Market Disclosure Regulations and Article 18 of its Enforcement Rules
- Other Reference Matters:
- Pursuant to Article 26 of the Enforcement Rules of the KOSDAQ Market Business Regulations, pre-market block trading/pre-open trading on the resumption date will not be executed.
- [Derivatives Market] Related stock futures and options listed on the underlying asset are simultaneously suspended from trading.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Subsequent Exchange Market Notices Regarding Trading Suspension
This disclosure formally announces the suspension of trading for ALTEOGEN’s common stock and related derivatives following the bonus issue announcement. Reviewing subsequent market notices regarding this trading suspension is essential because it allows investors to stay properly informed about the status and details of the applied market restriction. Detailed updates can be cross-checked in subsequent disclosure filings and KRX market notices.
📢 Disclaimer & Source Notice
Source: This content has been structured and newly created based on official filing data from the Financial Supervisory Service (DART).
Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.